Prenatal Exposure to Opioids and Neurodevelopmental Disorders in Children: A Bayesian Mediation Analysis
American Journal of Epidemiology · 05.02.2024 · 193 (2) · 308-322
DOI: 10.1093/aje/kwad183 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, online erschienen am 05.09.2023. Verfasst von Shuang Wang und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Neurodevelopmental Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
This study explores natural direct and joint natural indirect effects (JNIE) of prenatal opioid exposure on neurodevelopmental disorders (NDDs) in children mediated through pregnancy complications, major and minor congenital malformations, and adverse neonatal outcomes, using Medicaid claims linked to vital statistics in Rhode Island, United States, 2008–2018. A Bayesian mediation analysis with elastic net shrinkage prior was developed to estimate mean time to NDD diagnosis ratio using posterior mean and 95% credible intervals (CrIs) from Markov chain Monte Carlo algorithms. Simulation studies showed desirable model performance. Of 11,176 eligible pregnancies, 332 had ≥2 dispensations of prescription opioids anytime during pregnancy, including 200 (1.8%) having ≥1 dispensation in the first trimester (T1), 169 (1.5%) in the second (T2), and 153 (1.4%) in the third (T3). A significant JNIE of opioid exposure was observed in each trimester (T1, JNIE = 0.97, 95% CrI: 0.95, 0.99; T2, JNIE = 0.97, 95% CrI: 0.95, 0.99; T3, JNIE = 0.96, 95% CrI: 0.94, 0.99). The proportion of JNIE in each trimester was 17.9% (T1), 22.4% (T2), and 56.3% (T3). In conclusion, adverse pregnancy and birth outcomes jointly mediated the association between prenatal opioid exposure and accelerated time to NDD diagnosis. The proportion of JNIE increased as the timing of opioid exposure approached delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NICHD NIH HHS
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Essential Hospitals Institute
- CVS Health Foundation and Pharmacosmos Therapeutics, Inc.
- Japan Society for the Promotion of Science
Zitieren
APA
Wang, S., Puggioni, G., Wu, J., Meador, K. J., Caffrey, A., Wyss, R., Slaughter, J. L., Suzuki, E., Ward, K. E., Lewkowitz, A. K., & Wen, X. (2024). Prenatal Exposure to Opioids and Neurodevelopmental Disorders in Children: A Bayesian Mediation Analysis. American Journal of Epidemiology, 193(2), 308-322. https://doi.org/10.1093/aje/kwad183
Vancouver
Wang S, Puggioni G, Wu J, Meador KJ, Caffrey A, Wyss R, et al. Prenatal Exposure to Opioids and Neurodevelopmental Disorders in Children: A Bayesian Mediation Analysis. American Journal of Epidemiology. 2024;193(2):308-322. doi:10.1093/aje/kwad183
BibTeX
@article{Wang2024,
author = {Wang, Shuang and Puggioni, Gavino and Wu, Jing and Meador, Kimford J and Caffrey, Aisling and Wyss, Richard and Slaughter, Jonathan L and Suzuki, Etsuji and Ward, Kristina E and Lewkowitz, Adam K and Wen, Xuerong},
title = {Prenatal Exposure to Opioids and Neurodevelopmental Disorders in Children: A Bayesian Mediation Analysis},
journal = {American Journal of Epidemiology},
year = {2024},
volume = {193},
number = {2},
pages = {308--322},
doi = {10.1093/aje/kwad183}
}
EUVIMED